Skip to main content

Cancer Victim Gains $289 Million in Roundup Litigation

Cancer Victim Gains $289 Million in Roundup Litigation

Cancer Victim Gains $289 Million in Roundup Litigation

Introduction

In a landmark judgment on August 10, a San Francisco jury awarded the groundskeeper $250 million in punitive damages and nearly $40 million in compensatory damages over his alleged cancer.

The plaintiff, who is nearing death, argued for about $412 million in punitive damages and $39 million in compensatory damages over allegations that Monsanto's Roundup weedkiller and Ranger Prov herbicides caused him non-Hodgkin's lymphoma (NHL) in 2014. The plaintiff's win serves as an example for millions struggling to prove their case against the agricultural giant. His case was the first to undergo trial among several hundred affected due to the weedkiller.

While Monsanto officials continue to deny Roundup's involvement in causing deadly cancer, a spokesperson expressed that they are planning to appeal the jury's decision and stand by the product's safety. Roundup lawsuits are consolidated as a part of multidistrict litigation (MDL No. 2741; In Re: Roundup Products Liability Litigation), which holds more than 2,200 lawsuits, presided over by Judge Vince Chhabria, in the U.S. District Court of  San Francisco.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Appeals Court Upholds $611M Roundup Verdict

Categories: Roundup

A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.

The case involved three plaintiffs from New…

Valsartan “Wave 2” Bellwether Trial Schedule Set by Court

Categories: Valsartan

As the first Valsartan bellwether trial approaches in September 2025, the federal judge overseeing the multidistrict litigation (MDL) is preparing a second set of trials.

This move comes in anticipation of the possibility that parties may…

FDA Launches New Panel to Review Talc Safety

Categories: Talcum

A panel of independent scientific experts convened this week at the request of the U.S. Food and Drug Administration (FDA) to evaluate the potential health risks associated with talc…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!